Login Get Started
Browse
Shares
Healthcare
Biotechnology & Medical Research
Antisense Therapeutics
Antisense Therapeutics logo

ANP - Antisense Therapeutics News Story

A$0.18 0.0  0.0%

Last Trade - 5:10am

Sector
Healthcare
RiskRating
Highly Speculative
Size
Micro Cap
Style
Momentum Trap
Market Cap £49.6m
Enterprise Value £47.4m
Revenue £17.2k
Position in Universe 897th / 1831
Quality
Value
Momentum
StockRank™
StockReport™
Tools
Compare with... Run through checklist
Accounts
Balance sheet Income statement Cashflow statement Dividend summary
Charts News Discussions ANP Dividends
All News

Australia Stock Exchange release from ANTISENSE THERAP : Change of Registered Office and Principal Place of Business

Antisense Therapeutics News
Thu 14th January, 2021 12:00am
Australia Stock Exchange release from ANTISENSE THERAP  ANP.AX : Change of Registered Office and Principal Place of Business

Recent news on Antisense Therapeutics

See all news
Australia Stock Exchange release from ANTISENSE THERAP : Jett Foundation 4th Annual Rare Disease Day
Thu 10:39pm News
Australia Stock Exchange release from ANTISENSE THERAP : PRE_NR Ends: 08:58:12
Wed 9:47pm News
Australia Stock Exchange release from ANTISENSE THERAP : ATL1102 DMD Paediatric Investigation Plan submitted to EMA
Wed 9:47pm News
Australia Stock Exchange release from ANTISENSE THERAP : Company Secretary Appointment
Wed 5:37am News
Australia Stock Exchange release from ANTISENSE THERAP : PRE_NR Ends: 16:41:07
Wed 5:30am News
© Stockopedia 2021, Refinitiv, Share Data Services.
Youtube Instagram RSS
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.